ARCHIVES

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

FCRF Recompetition Notice Of Intent

September 19, 1980

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

In Brief: NCI’s “Constant Dollar” Budget For FY 1979 Equal To 1975 Amount; Decosse Move to S-K

September 22, 1978

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

Pennsylvania House Approves Bills Establishing Control, Research Funds With Cigarette Tax

August 11, 1978